Biomarkers are biological molecules that indicate the presence or progression of a disease. In cancer, biomarkers can help in early detection, diagnosis, prognosis, and monitoring treatment response. Examples include PSA for prostate cancer, CA-125 for ovarian cancer, and HER2 for breast cancer. The development of novel biomarkers through advances in proteomics and metabolomics holds promise for improving cancer management.
